Recent News

Call Your State Senators to Oppose the Furthering Asbestos Claims Transparency Act

March 24, 2017

A new bill was approved by the U.S. House Judiciary Committee that could damage the asbestos claims process and prevent victims of asbestos-related diseases from ever seeing any sort of[…]

Read More

Nutritional Status and Tumor Thickness Helps Determine Mesothelioma Prognosis

March 20, 2017

The overall nutritional health of a patient suffering from mesothelioma can have major impact on how the patient will respond to treatment, which affects patient survival. To determine a patient’s[…]

Read More

Despite Asbestos Regulations, CDC Reports Increase in Mesothelioma

March 13, 2017

Mesothelioma is a type of cancer that is specifically caused by asbestos exposure. The cancer affects the lining surrounding various organs and cavities within the body called the mesothelium. Asbestos[…]

Read More

Partial Repeal in the ACA Preserves Provisions for Residents in Libby, Montana

March 8, 2017

The dangers of asbestos have affected thousands of residents in the small town of Libby, Montana for decades. In 1919, the town that was once known for its logging industry[…]

Read More

Immunotherapy Drug Tremelimumab Not As Effective As Hoped

March 3, 2017

Mesothelioma’s aggressive nature makes it difficult to treat with common cancer treatments such as chemotherapy and radiation. Scientists and researchers are constantly looking for new ways to treat mesothelioma outside[…]

Read More

The Latest Clinical Trial for Nintedanib – Are You a Candidate?

February 24, 2017

Scientists and researchers are excited over the latest completion of a Phase II clinical trial for those suffering from mesothelioma – an incurable asbestos-caused cancer that has a median survival[…]

Read More

Lack of Treatment Responses for Mesothelioma, Proteins Combat Metastasis

February 13, 2017

Mesothelioma is an incredibly difficult cancer to treat. Its late stage diagnosis coupled with its aggressive nature leaves victims without very much time to combat this fatal cancer. There are[…]

Read More

Lung-Sparing Surgery Dramatically Improves Prognosis for Mesothelioma Patients

January 31, 2017

Those suffering from mesothelioma know that the prognosis is grim. The average life expectancy for someone who is recently diagnosed is only eight months. Chemotherapy is the standard treatment for[…]

Read More

Chemical Components In Peppers and Sea Cucumbers May Combat Mesothelioma

January 13, 2017

Mesothelioma is difficult to treat for a number of reasons. The long latency period before initial diagnosis means that the cancer is typically in advanced stages by the time it[…]

Read More

Positive Response for Immunotherapy Treatment KEYTRUDA ®

December 12, 2016

Scientists and researchers from Merck announced an update on their findings for the Phase 1b KEYNOTE-28 study that involves the investigation of the immunotherapy treatment called KEYTRUDA ® (pembrolizumab). The[…]

Read More